| Lab-on-a-chip (36) |  |
| Nanodrug (17) | |
| Nanomedicine (72) | |
| Lab-on-a-chip (36) | |
| Nanodrug (17) | |
| Nanomedicine (72) | |
IBM recently made a#breakthrough with a nanomedicine#that it can engineer to latch on to fungal cells in the body
and Paula Hammond, the David H. Koch Professor in Engineering, describe the findings in the May 8 online edition of Science Signaling. think it a harbinger of what nanomedicine can do for us in the future,
In a huge step forward in the use of nanomedicine the research helped discover proteins in the blood that disguise nanoparticles
Our breakthrough will open up new doors in the various fields of nanomedicine bioimaging and cancer therapeutics.
Das and Walker Julie AK Mcdonald (Kingston General Hospital) Dr. Petrof (KGH) and Emma Allen-Vercoe (University of Guelph) were published in the Journal of Nanomedicine and Nanotechnology.
This is an exciting breakthrough in nanomedicine said IBN Executive director Professor Jackie Y. Ying. A key challenge in chemotherapy is ensuring that the drugs are delivered only to the tumor
"It is important as it presents new possible applications in green solvents or bioimaging and nanomedicine fields
and tissues,"said Ennio Tasciotti, Co-Chair, Department of Nanomedicine at Houston Methodist Research Institute and co-corresponding author of the paper."
"Genisphere's partnership model for development of nanotherapeutics has set the path forward for clinical testing and future commercialization of these and other candidates. t
Zharov is director of the Arkansas Nanomedicine Center at the UAMS Winthrop P. Rockefeller Cancer Institute and a professor in the UAMS College of Medicine Department of Otolarynology-Head and Neck Surgery.
"This work addresses a major challenge in the field of nanomedicine: targeted drug delivery with nanoparticles,
a biomedical engineer and faculty member at the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins. Researchers funded by the National Institute of Biomedical Imaging and Bioengineering meanwhile,
and then it must be degraded--the components are recycled then basically,"added Marth, also director of UCSB's Center for Nanomedicine and a professor in the campus's Department of Molecular, Cellular, and Developmental biology."
"said lead author Won Ho Yang, Ph d.,a postdoctoral associate at SBP and at UCSB's Center for Nanomedicine."
and turnover,"said senior author Jamey Marth, director of UCSB's Center for Nanomedicine and a professor in the campus's Department of Molecular, Cellular, and Developmental biology."
"said lead author Won Ho Yang, a postdoctoral associate at UCSB's Center for Nanomedicine and SBP."
Funding for this study was provided by a Boston University Nanomedicine grant and NIH P50hl083801 to James Hamilton and by the Howard Hughes Medical Institute and NIH CA158448 to the Roger Tsien group p
and will be published in the journal Nanomedicine. They state that the biodegradable material could be used to heal bones in hundreds of thousands of patients requiring bone replacement
#Advance in photodynamic therapy offers new approach to ovarian cancer The findings were published just in the journal Nanomedicine:
"This work addresses a major challenge in the field of nanomedicine: targeted drug delivery with nanoparticles,
#Spherical nucleic acids set stage for new paradigm in nanomedicine drug development A research team led by Northwestern University nanomedicine expert Chad A. Mirkin
. a research associate at the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins Medicine.
Thats 100 percent efficacy, a very promising finding, says Justin Hanes, Ph d.,director of the Center for Nanomedicine.
The results appear in the journal Nanomedicine: Nanotechnology, Biology and Medicine. While current HIV treatments involve pills that are taken daily,
The results appear in the journal Nanomedicine: Nanotechnology, Biology and Medicine. While current HIV treatments involve pills that are taken daily,
The results appear in the journal Nanomedicine: Nanotechnology, Biology and Medicine. While current HIV treatments involve pills that are taken daily,
. a biomedical engineer and faculty member at the Center for Nanomedicine at the Wilmer Eye Institute at Johns Hopkins. A report on the work appeared in the Proceedings of the National Academy of Sciences on June 29.
#Optimal particle size for anticancer nanomedicines discovered Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues
Understanding the interdependency of physiochemical properties of nanomedicines in correlation to their biological responses and functions is crucial for their further development of as cancer-fighters.
To develop next generation nanomedicines with superior anticancer attributes we must understand the correlation between their physicochemical properties--specifically particle size
While most current approved anticancer nanomedicines'sizes range from 100-200 nm recent studies showed that anticancer nanomedicines with smaller sizes--specifically of 50 nm
Our studies show clear evidence that there is an optimal particle size for anticancer nanomedicines resulting in the highest tumor retention.
To further develop insight into the size dependency of nanomedicines in tumor accumulation and retention the researchers developed a mathematical model of the spatiotemporal distribution of nanoparticles within a spherically symmetric tumor.
The results are extremely important to guide the future research in designing new nanomedicines for cancer treatment Cheng noted
In addition a new nanomedicine developed by the Illinois researchers--with precisely engineered size at the optimal size range--effectively inhibited a human breast cancer
#Sticky-Flare Nanotechnology Reveals RNA Misregulation in Living Cells A new technology--called"Sticky-flares"--developed by nanomedicine experts at Northwestern University offers the first real-time method to track
"said Chad A. Mirkin, a nanomedicine expert and corresponding author of the study.""We hope that many more researchers will be able to use this platform to increase our understanding of RNA function inside cells."
which was published online in the journal Nanomedicine: Nanotechnology, Biology and Medicine, was led by Jeffrey Zink and Fuyu Tamanoi, both members of the California Nanosystems Institute and Jonsson Comprehensive Cancer Center at UCLA,
a nanomedicine expert at Northwestern University and corresponding author of the study. e hope that many more researchers will be able to use this platform to increase our understanding of RNA function inside cells.
2015turmeric Extract Applied in Production of Antibacterial Nanodrugs March 12th, 2015nobel Laureate Martin Chalfie to Address International Nanomedicine Conference March 11th,
News and information Nanotherapy effective in mice with multiple myeloma May 21st, 2015turn that defect upside down:
2015discoveries Nanotherapy effective in mice with multiple myeloma May 21st, 2015turn that defect upside down: Twin boundaries in lithium-ion batteries May 21st, 2015insidde:
2015announcements Nanotherapy effective in mice with multiple myeloma May 21st, 2015turn that defect upside down: Twin boundaries in lithium-ion batteries May 21st, 2015insidde:
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Nanotherapy effective in mice with multiple myeloma May 21st, 2015turn that defect upside down:
Ljubimova, director of the Nanomedicine Research center in the Department of Neurosurgery and director of the Nanomedicine Program at the Samuel Oschin Comprehensive Cancer Institute, has received a $2. 5 million grant from the National institutes of health to continue the research.
News and information A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015discoveries A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015announcements A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers A step towards a type 1 diabetes vaccine by using nanotherapy June 10th,
#Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval CEA-Leti today announced the launch of the European Nano-Characterisation Laboratory (EU
-NCL) funded by the European union Horizon 2020 research and innovation programm 1 e. Its main objective is to reach a level of international excellence in nanomedicine characterisation for medical indications like cancer, diabetes, inflammatory diseases or infections,
and make it accessible to all organisations developing candidate nanomedicines prior to their submission to regulatory agencies to get the approval for clinical trials and, later,
marketing authorization. s reported in the ETPN White paper 2, there is a lack of infrastructure to support nanotechnology-based innovation in healthcare,
said Patrick Boisseau, head of business development in nanomedicine at CEA-Leti and chairman of the European Technology Platform Nanomedicine (ETPN).
anocharacterisation is the first bottleneck encountered by companies developing nanotherapeutics. The EU-NCL project is of most importance for the nanomedicine community,
as it will contribute to the competiveness of nanomedicine products and tools and facilitate regulation in Europe.
EU-NCL is partnered with the sole international reference facility, the Nanotechnology Characterization Lab of the National Cancer Institute in the U s. US-NCL) 3,
director of U s. NCL. e hope this collaboration will help standardize regulatory requirements for clinical evaluation and marketing of nanomedicines internationally.
as it will be the first transnational infrastructure in nanomedicine. It aims at fostering innovation by sharing knowledge and technologies between academia and industry.
and will also develop new or improved analytical assays to keep EU-NCL at the cutting edge of nanomedicine characterisation.
Published in Nanomedicine, the study identified a new mechanism of targeting multi-subunit complexes that are critical to the function of viruses, bacteria or cancer,
and industries, including laser, solar cells, production of transistors and nanomedicine. The colloid form of these particles have very interesting properties and characteristics,
Published in Nanomedicine("New approach to develop ultra-high inhibitory drug using the power function of the stoichiometry of the targeted nanomachine or biocomplex),
A new technology--called"Sticky-flares"--developed by nanomedicine experts at Northwestern University offers the first real-time method to track
"said Chad A. Mirkin, a nanomedicine expert and corresponding author of the study.""We hope that many more researchers will be able to use this platform to increase our understanding of RNA function inside cells."
The University of Tokyo (concurrently serving as the Director of the Innovation Center of Nanomedicine,
"The results provide the first demonstration of a successful non-viral nanomedicine method for HSVTK/ganciclovir treatment of brain cancer,"stated Green."
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011